ID 1842 -
Proteaza, lipaza, enzymy trawiące węglowodany
PL: Proteaza, lipaza, enzymy trawiące węglowodany
EN: Protease, lipase and other enzymes that break down carbohydrates
Pdf: various food(s)/food constituent(s)
1.11. Poprawa trawienia makroskładników (węglowodanów, białek, tłuszczów) (ID 1781, 1842, 2825, 3137, 3519, 3972, 4662, 4691)
The claimed effects are ―digestive function‖, ―digestion‖, ―break down of high-molecules compound from food‖, ―pancreas‖ and ―digestive system benefits‖. The Panel assumes that the target population is the general population.
In the context of the proposed wordings and clarifications provided by Member States, the Panel assumes that the claimed effects refer to the facilitation of the digestion of macronutrients (e.g. dietary carbohydrates, proteins and lipids) in the gastro-intestinal tract.
The human gastro-intestinal tract capacity for digestion of macronutrients is very high and it is estimated that in physiological situation it exceeds tenfold the biological demand. The Panel considers that macronutrient digestion is not impaired in the general population and that no evidence has been provided that an improvement of the digestion of macronutrients (e.g. carbohydrates, proteins and lipids) is a beneficial physiological effect per se for the general population.
The Panel concludes that a cause and effect relationship has not been established between the consumption of the food(s)/food constituent(s) which are the subject of the health claims and a beneficial physiological effect related to the digestion of carbohydrates, proteins and lipids.
Warunki i możliwe ograniczenia stosowania oświadczenia
Food supplement containing protease enzymes (protease 2.5 18000 HUT, protease 3.0 10 SAPU and protease 6.0 4000 HUT units/daily dose and proteases, lipases and enzymes that break down carbohydrates (amylase 7500 DU, glucoamylase 10 AGU, cellulase 125 CU, malt diastase 250 DP and invertase 250 SU, lipase RO 437.5 FIP units/daily dose.
